Slideshow

January 3, 2016

FDA Updates in Endocrinology

The end of the year brought many new FDA developments, including approval of a long-acting insulin and updated warnings for SGLT2 inhibitors.

Recent FDA news is outlined in the following slides.

Related Videos

Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University

Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn

Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive

Viet Le, DMSc, PA-C | Credit: APAC

Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive

Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

HCPLive CKD and CVD NewsNetwork Thumbnail

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.